Table 1 Demographic and clinical data of study participants
|  | ICAS (n = 347) | WICAS (n = 526) | p value |
|---|---|---|---|
Men/female, n | 118:229 | 192:334 | 0.384b |
Age (years ± SD) | 72.1 ± 3.9 | 71.8 ± 3.8 | 0.157a |
Diabetes duration, (years ± SD) | 13.3 ± 4.5 | 12.2 ± 3.4 | 0.209a |
BMI (Kg/m2 ± SD) | 30.7 ± 6.3 | 27.9 ± 4.6 | < 0.01a |
Smoking (current), n (%) | 116 (33.4) | 172 (32.7) | 0.185b |
Smoking (former), n (%) | 145 (41.8) | 221 (42.0) | 0.261b |
Hypertension, n (%) | 221 (63.7) | 215 (40.9) | < 0.01b |
CAD, n (%) | 189 (54.5) | 164 (31.2) | < 0.01b |
HIS, n (%) | 164 (47.3) | 0 (0.0) | < 0.01b |
PAD, n (%) | 119 (34.3) | 113 (21.5) | < 0.01b |
Hypercholesterolemia, n (%) | 275 (79.3) | 153 (29.1) | < 0.01b |
LDL-C (mg/dL ± SD) | 154 ± 14.6 | 102 ± 11.2 | < 0.01b |
Triglycerides (mg/dL ± SD) | 194 ± 20.1 | 139 ± 15.4 | < 0.01b |
Statins, n (%) | 274 (78.9) | 156 (29.7%) | < 0.01b |
Antihypertensive drugs, n (%) | 223 (64.3) | 214 (40.7) | < 0.01b |
Anti-diabetic treatment | |||
 Diet only, n (%) | 36 (10.4) | 56 (10.6) | 0.349b |
 Oral agents, n (%) | 169 (48.7) | 259 (49.2) | 0.328b |
 Insulin therapy, n (%) | 142 (40.9) | 211 (40.2) | 0.243b |